{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T09:25:01Z","timestamp":1769246701183,"version":"3.49.0"},"reference-count":34,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:00:00Z","timestamp":1764892800000},"content-version":"vor","delay-in-days":1362,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2022,3,14]],"date-time":"2022-03-14T00:00:00Z","timestamp":1647216000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>The role of serum type III procollagen peptide (P3P) level in the acute phase of acute heart failure (AHF) requires clarification. We hypothesized that serum P3P level is temporarily higher during the acute phase, reflecting liver dysfunction due to congestion.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>A total of 800 AHF patients were screened, and data from 643 patients were analysed. Heart failure was diagnosed by the treating physician according to the European Society of Cardiology (ESC) guidelines, and included patients being treated with high-concentration oxygen inhalation (including mechanical support) for orthopnea, inotrope administration, or mechanical support for low blood pressure, and various types of diuretics for peripheral or pulmonary oedema. In all cases, diuretics or vasodilators were administered to treat AHF. The patients were divided into three groups according to their quartile (Q) serum P3P level: low-P3P (Q1, P3P \u2264 0.6 U\/mL), mid-P3P (Q2\/Q3, 0.6 &amp;lt; P3P &amp;lt;1.2 U\/mL), and high-P3P (Q4, P3P \u2265 1.2 U\/mL). The plasma volume status (PVS) was calculated using the following formula: ([actual PV \u2212 ideal PV]\/ideal PV) \u00d7 100 (%). The primary endpoint was 365 day mortality. A Kaplan\u2013Meier curve analysis showed that prognoses, including all-cause mortality and heart failure events within 365 days, were significantly (P &amp;lt; 0.001) worse in the high-P3P group when compared with the mid-P3P and low-P3P groups. A multivariate logistic regression analysis showed that high PVS (Q4, odds ratio [OR]: 4.702, 95% CI: 2.012\u201320.989, P &amp;lt; 0.001), high fibrosis-4 index (Q4, OR: 2.627, 95% CI: 1.311\u20135.261, P = 0.006), and low estimated glomerular filtration rate per 10 mL\/min\/1.73 m2 decrease (OR: 1.996, 95% CI: 1.718\u20132.326, P &amp;lt; 0.001) were associated with high P3P values. The Kaplan\u2013Meier curve analysis demonstrated a significantly lower survival rate, as well as a higher rate of heart failure events, in the high-P3P and high-PVS groups when compared with the other groups. A multivariate Cox regression model identified high P3P level and high PVS as an independent predictor of 365 day all-cause mortality (hazard ratio [HR]: 2.249; 95% CI: 1.081\u20133.356; P = 0.026) and heart failure events (HR: 1.586, 95% CI: 1.005\u20132.503, P = 0.048).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>A high P3P level during the acute phase of AHF served as a comprehensive biomarker of liver dysfunction with volume overload (i.e. liver congestion) and renal dysfunction. A high P3P level at admission may be able to predict adverse outcomes in AHF patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/ehf2.13878","type":"journal-article","created":{"date-parts":[[2022,3,15]],"date-time":"2022-03-15T01:34:06Z","timestamp":1647308046000},"page":"1832-1843","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Type III Procollagen Peptide Level can Indicate Liver Dysfunction Associated with Volume Overload in Acute Heart Failure"],"prefix":"10.1093","volume":"9","author":[{"given":"Akihiro","family":"Shirakabe","sequence":"first","affiliation":[{"name":"Division of Intensive Care Unit, Nippon Medical School Chiba Hokusoh Hospital , 1715 Kamagari, Inzai, Chiba, 270-1694 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirotake","family":"Okazaki","sequence":"additional","affiliation":[{"name":"Division of Intensive Care Unit, Nippon Medical School Chiba Hokusoh Hospital , 1715 Kamagari, Inzai, Chiba, 270-1694 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masato","family":"Matsushita","sequence":"additional","affiliation":[{"name":"Division of Intensive Care Unit, Nippon Medical School Chiba Hokusoh Hospital , 1715 Kamagari, Inzai, Chiba, 270-1694 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusaku","family":"Shibata","sequence":"additional","affiliation":[{"name":"Division of Intensive Care Unit, Nippon Medical School Chiba Hokusoh Hospital , 1715 Kamagari, Inzai, Chiba, 270-1694 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shota","family":"Shigihara","sequence":"additional","affiliation":[{"name":"Division of Intensive Care Unit, Nippon Medical School Chiba Hokusoh Hospital , 1715 Kamagari, Inzai, Chiba, 270-1694 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suguru","family":"Nishigoori","sequence":"additional","affiliation":[{"name":"Division of Intensive Care Unit, Nippon Medical School Chiba Hokusoh Hospital , 1715 Kamagari, Inzai, Chiba, 270-1694 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomofumi","family":"Sawatani","sequence":"additional","affiliation":[{"name":"Division of Intensive Care Unit, Nippon Medical School Chiba Hokusoh Hospital , 1715 Kamagari, Inzai, Chiba, 270-1694 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nozomi","family":"Sasamoto","sequence":"additional","affiliation":[{"name":"Division of Intensive Care Unit, Nippon Medical School Chiba Hokusoh Hospital , 1715 Kamagari, Inzai, Chiba, 270-1694 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazutaka","family":"Kiuchi","sequence":"additional","affiliation":[{"name":"Division of Intensive Care Unit, Nippon Medical School Chiba Hokusoh Hospital , 1715 Kamagari, Inzai, Chiba, 270-1694 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanori","family":"Atsukawa","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Nippon Medical School , Tokyo ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norio","family":"Itokawa","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Nippon Medical School , Tokyo ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taeang","family":"Arai","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Nippon Medical School , Tokyo ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuaki","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Division of Intensive Care Unit, Nippon Medical School Chiba Hokusoh Hospital , 1715 Kamagari, Inzai, Chiba, 270-1694 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuniya","family":"Asai","sequence":"additional","affiliation":[{"name":"Division of Intensive Care Unit, Nippon Medical School Chiba Hokusoh Hospital , 1715 Kamagari, Inzai, Chiba, 270-1694 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2022,3,14]]},"reference":[{"key":"2026012114235036400_ehf213878-bib-0001","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0168-8278(91)90929-6","article-title":"Serum type I collagen and N-terminal peptide of type III procollagen in chronic hepatitis. Relationship to liver histology and conventional liver tests","volume":"12","author":"Trinchet","year":"1991","journal-title":"J Hepatol"},{"key":"2026012114235036400_ehf213878-bib-0002","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1111\/j.1530-0277.2008.00664.x","article-title":"Value of fibrosis markers for staging liver fibrosis in patients with precirrhotic alcoholic liver disease","volume":"32","author":"Lieber","year":"2008","journal-title":"Alcohol Clin Exp Res"},{"key":"2026012114235036400_ehf213878-bib-0003","first-page":"1437","article-title":"Procollagen-III peptide and chronic viral C hepatitis","volume":"90","author":"Jeffers","year":"1995","journal-title":"Am J Gastroenterol"},{"key":"2026012114235036400_ehf213878-bib-0004","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1093\/europace\/eus162","article-title":"Type III procollagen-N-peptide as a predictor of persistent atrial fibrillation recurrence after cardioversion","volume":"14","author":"Kawamura","year":"2012","journal-title":"Europace"},{"key":"2026012114235036400_ehf213878-bib-0005","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/S0002-9149(99)80251-3","article-title":"The aminoterminal propeptide of type III procollagen provides new information on prognosis after acute myocardial infarction","volume":"76","author":"Host","year":"1995","journal-title":"Am J Cardiol"},{"key":"2026012114235036400_ehf213878-bib-0006","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1093\/eurheartj\/ehs332","article-title":"Liver function abnormalities, clinical profile, and outcome in acute decompensated heart failure","volume":"34","author":"Nikolaou","year":"2013","journal-title":"Eur Heart J"},{"key":"2026012114235036400_ehf213878-bib-0007","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/ejhf.440","article-title":"Liver function tests in patients with acute heart failure and associated outcomes: insights from ASCEND-HF","volume":"18","author":"Samsky","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"2026012114235036400_ehf213878-bib-0008","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.cardfail.2014.05.001","article-title":"Longitudinal trends, hemodynamic profiles, and prognostic value of abnormal liver function tests in patients with acute decompensated heart failure: an analysis of the ESCAPE trial","volume":"20","author":"Scholfield","year":"2014","journal-title":"J Card Fail"},{"key":"2026012114235036400_ehf213878-bib-0009","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/ejhf.592","article-title":"ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"18","author":"Ponikowski","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"2026012114235036400_ehf213878-bib-0010","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/ejhf.193","article-title":"Calculated plasma volume status and prognosis in chronic heart failure","volume":"17","author":"Ling","year":"2015","journal-title":"Eur J Heart Fail"},{"key":"2026012114235036400_ehf213878-bib-0011","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/hep.21669","article-title":"FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotest","volume":"46","author":"Vallet-Pichard","year":"2007","journal-title":"Hepatology"},{"key":"2026012114235036400_ehf213878-bib-0012","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.cgh.2009.05.033","article-title":"Nash Clinical Research N. Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease","volume":"7","author":"Shah","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2026012114235036400_ehf213878-bib-0013","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1111\/apt.14619","article-title":"Fibrosis-4 index predicts cirrhosis risk and liver-related mortality in 2075 patients with chronic HBV infection","volume":"47","author":"Tseng","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"2026012114235036400_ehf213878-bib-0014","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1007\/s00380-019-01505-y","article-title":"Fibrosis-4 index reflects right-sided filling pressure in patients with heart failure","volume":"35","author":"Maeda","year":"2020","journal-title":"Heart Vessels"},{"key":"2026012114235036400_ehf213878-bib-0015","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2017-000598","article-title":"Liver stiffness assessed by Fibrosis-4 index predicts mortality in patients with heart failure","volume":"4","author":"Sato","year":"2017","journal-title":"Open Heart"},{"key":"2026012114235036400_ehf213878-bib-0016","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ijcard.2020.09.056","article-title":"Impact of predictive value of Fibrosis-4 index in patients hospitalized for acute heart failure","volume":"324","author":"Shibata","year":"2021","journal-title":"Int J Cardiol"},{"key":"2026012114235036400_ehf213878-bib-0017","first-page":"330","article-title":"Plasma volume status predicts prognosis in patients with acute heart failure syndromes","volume":"7","author":"Yoshihisa","year":"2018","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"2026012114235036400_ehf213878-bib-0018","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s00392-018-1388-y","article-title":"Diagnostic and prognostic value of plasma volume status at emergency department admission in dyspneic patients: results from the PARADISE cohort","volume":"108","author":"Chouihed","year":"2019","journal-title":"Clin Res Cardiol"},{"key":"2026012114235036400_ehf213878-bib-0019","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s00392-018-1385-1","article-title":"Prognostic value of estimated plasma volume in acute heart failure in three cohort studies","volume":"108","author":"Kobayashi","year":"2019","journal-title":"Clin Res Cardiol"},{"key":"2026012114235036400_ehf213878-bib-0020","doi-asserted-by":"crossref","first-page":"S129","DOI":"10.1097\/01.CCM.0000296274.51933.4C","article-title":"Practical recommendations for prehospital and early in-hospital management of patients presenting with acute heart failure syndromes","volume":"36","author":"Mebazaa","year":"2008","journal-title":"Crit Care Med"},{"key":"2026012114235036400_ehf213878-bib-0021","first-page":"1342","article-title":"2017 Comprehensive Update of the Canadian Cardiovascular Society Guidelines for the Management of Heart Failure","volume":"33","author":"Ezekowitz","year":"2017","journal-title":"Can J Cardiol"},{"key":"2026012114235036400_ehf213878-bib-0022","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ahj.2006.02.038","article-title":"The pathophysiology of acute heart failure\u2014Is it all about fluid accumulation?","volume":"155","author":"Cotter","year":"2008","journal-title":"Am Heart J"},{"key":"2026012114235036400_ehf213878-bib-0023","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1001\/jama.1996.03540110043030","article-title":"The effectiveness of right heart catheterization in the initial care of critically ill patients","volume":"276","author":"Connors","year":"1996","journal-title":"JAMA"},{"key":"2026012114235036400_ehf213878-bib-0024","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.021808","article-title":"Invasive Hemodynamic Monitoring in Cardiogenic Shock Is Associated With Lower In-Hospital Mortality","volume":"10","author":"Osman","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"2026012114235036400_ehf213878-bib-0025","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.jchf.2020.08.012","article-title":"Complete Hemodynamic Profiling With Pulmonary Artery Catheters in Cardiogenic Shock Is Associated With Lower In-Hospital Mortality","volume":"8","author":"Garan","year":"2020","journal-title":"JACC Heart Fail"},{"key":"2026012114235036400_ehf213878-bib-0026","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1001\/jama.294.13.1625","article-title":"Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: the ESCAPE trial","volume":"294","author":"Binanay","year":"2005","journal-title":"JAMA"},{"key":"2026012114235036400_ehf213878-bib-0027","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1253\/circj.72.364","article-title":"Prognostic significance of increased serum bilirubin levels coincident with cardiac decompensation in chronic heart failure","volume":"72","author":"Shinagawa","year":"2008","journal-title":"Circ J"},{"key":"2026012114235036400_ehf213878-bib-0028","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.cardfail.2009.08.002","article-title":"Abnormal liver function in relation to hemodynamic profile in heart failure patients","volume":"16","author":"van Deursen","year":"2010","journal-title":"J Card Fail"},{"key":"2026012114235036400_ehf213878-bib-0029","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1164\/ajrccm.159.3.9805060","article-title":"Type III and type I procollagen markers in fibrosing alveolitis","volume":"159","author":"Lammi","year":"1999","journal-title":"Am J Resp Crit Care Med"},{"key":"2026012114235036400_ehf213878-bib-0030","first-page":"165","article-title":"Increased levels of amino terminal propeptide of type III procollagen are an unfavourable predictor of survival in systemic sclerosis","volume":"23","author":"Nagy","year":"2005","journal-title":"Clin Exp Rheumatol"},{"key":"2026012114235036400_ehf213878-bib-0031","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1536\/ihj.51.404","article-title":"Clinical significance of matrix metalloproteinase (MMP)-2 in patients with acute heart failure","volume":"51","author":"Shirakabe","year":"2010","journal-title":"Int Heart J"},{"key":"2026012114235036400_ehf213878-bib-0032","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1161\/CIRCHEARTFAILURE.108.844324","article-title":"Episodes of acute heart failure syndrome are associated with increased levels of troponin and extracellular matrix markers","volume":"3","author":"Biolo","year":"2010","journal-title":"Circ Heart Fail"},{"key":"2026012114235036400_ehf213878-bib-0033","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s11897-011-0071-7","article-title":"Impact of systemic venous congestion in heart failure","volume":"8","author":"Dupont","year":"2011","journal-title":"Current Heart Fail Rep"},{"key":"2026012114235036400_ehf213878-bib-0034","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1002\/ehf2.12264","article-title":"Worsening renal function definition is insufficient for evaluating acute renal failure in acute heart failure","volume":"5","author":"Shirakabe","year":"2018","journal-title":"ESC Heart Fail"}],"container-title":["ESC Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ehf2.13878","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/ehf2.13878","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/9\/3\/1832\/65668979\/eschf_9_3_1832.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/9\/3\/1832\/65668979\/eschf_9_3_1832.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T19:29:52Z","timestamp":1769023792000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eschf\/article\/9\/3\/1832\/8362455"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,14]]},"references-count":34,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022,3,14]]},"published-print":{"date-parts":[[2022,6,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ehf2.13878","relation":{},"ISSN":["2055-5822"],"issn-type":[{"value":"2055-5822","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,6]]},"published":{"date-parts":[[2022,3,14]]},"assertion":[{"value":"2021-10-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-02-28","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-03-14","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}